Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The Head, The Heart and The Gut

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jan 31, 2023 12:48pm

217 Views

Post# 35257175

RE:RE:RE:RE:RE:The Head, The Heart and The Gut

TLT will put itself on sales after GBM and NSCLC Ph. 1b.

It's been clear right before they even started NMIBC Ph. 1b.

So far, all this under a shoestring R&D budget and with higher efficacy than any big pharma and biotech has ever been close to deliver over the last 50y.

Without the many initiatives of Roger, nothing of all this would have happened. The molecule of Dr. McFarland would have found no taker. It took a multidisciplinary team to bring all this to bedside and this took a visionary.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles